Penumbra

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.

About PEN

Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system.

CEO

Adam Elsesser

CEOAdam Elsesser

Employees

4,500

Employees4,500

Headquarters

Alameda, California

HeadquartersAlameda, California

Founded

2004

Founded2004

Employees

4,500

Employees4,500

PEN Key Statistics

Market cap

9.99B

Market cap9.99B

Price-Earnings ratio

67.89

Price-Earnings ratio67.89

Dividend yield

—

Dividend yield—

Average volume

362.44K

Average volume362.44K

High today

$260.62

High today$260.62

Low today

$252.77

Low today$252.77

Open price

$253.78

Open price$253.78

Volume

358.19K

Volume358.19K

52 Week high

$310.00

52 Week high$310.00

52 Week low

$190.08

52 Week low$190.08

PEN News

Simply Wall St 24h

STORM-PE Trial Completion and New Launches Could Be a Game Changer for Penumbra

In September 2025, Penumbra promoted Shruthi Narayan to President and launched the Ruby XL System and Lightning Bolt 6X device, while also completing enrollment...

Simply Wall St 2d

A Fresh Look at Penumbra Valuation After Modest Share Price Movement

Penumbra (PEN) shares saw modest movement today, closing at $253.49. In the past month, the stock dipped about 6%. For investors tracking healthcare equipment t...

Analyst ratings

76%

of 21 ratings

Buy

76.2%

Hold

19%

Sell

4.8%

People also own

Based on the portfolios of people who own PEN. This list is generated using Robinhood data, and it’s not a recommendation.